Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Ofatumumab
Active Biotech's partner Teva initiates a further clinical trial in multiple sclerosis
Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally in Patients With Relapsing-remitting Multiple Sclerosis
Amiloride: a molecular probe of sodium transport in tissues and cells.
BRAVO Study: Laquinimod Double Blind Placebo Controlled Study in RRMS Patients With a Rater Blinded Reference Arm of Interferon β-1a (Avonex®)
Human endogenous retroviruses and multiple sclerosis: innocent bystanders or disease determinants?
Good Early Results for HERV Suppressor in MS
GlaxoSmithKline and Genmab refocus development programme for ofatumumab in autoimmune indications
Pattern of demyelination occurring during anti-TNF-α therapy: a French national survey.
Abnormal inflammatory activity returns after natalizumab cessation in multiple sclerosis.
The effect of vitamin a supplementation on biochemical parameters in multiple sclerosis patients.
Lights and shadows of cyclophosphamide in the treatment of multiple sclerosis.
Effects of Inhibitors of the Renin-Angiotensin System on the Efficacy of Interferon beta-1b: A post hoc Analysis of the BEYOND Study.
1,25-dihydroxyvitamin D(3) ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A.
Colestipol May Quickly Eliminate Teriflunomide
Cutting Edge: Integrin α4 Is Required for Regulatory B Cell Control of Experimental Autoimmune Encephalomyelitis.
Volumetric comparisons of supratentorial white matter hyperintensities on FLAIR MRI in patients with migraine and multiple sclerosis.
Binding of recombinant T cell receptor ligands (RTL) to antigen presenting cells prevents upregulation of CD11b and inhibits T cell activation and transfer of experimental autoimmune encephalomyelitis.
Immune status following alemtuzumab treatment in human CD52 transgenic mice.
Glatiramer acetate treatment normalizes deregulated microRNA expression in relapsing remitting multiple sclerosis.
Genmab Announces Ofatumumab Development Plans in RRMS and NMO
Tecfidera(®): an approach for repurposing.
[Evaluation and quantification of spasticity: a review of the clinical, biomechanical and neurophysiological methods].
Morphological differentiation of oligodendrocytes requires activation of Fyn tyrosine kinase.
Glatiramer acetate-induced acute hepatotoxicity in an adolescent with MS.

Pages